Takashi Haku

Serum levels of interleukin 6 in patients with lung cancer

Hiroaki Yanagawa, S Sone, Yûji Takahashi et al. · British Journal of Cancer · 1995 · 166 citations · Full text

Cytokine, Cancer Immunosurveillance, Lung Inflammation +9

A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome

Koichiro Suemori, Masayuki Saijo, Atsushi Yamanaka et al. · PLoS neglected tropical diseases · 2021 · 71 citations · Full text

Real-world effectiveness and safety of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study in Japan

Ryo Morita, Kyoichi Okishio, Junichi Shimizu et al. · Lung Cancer · 2019 · 70 citations · Full text

Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages

Roustem Nabioullin, Saburo Sone, Kazuto Mizuno et al. · Journal of Leukocyte Biology · 1994 · 62 citations

Contrasting effect of interleukin-13 on interleukin-1 receptor antagonist and proinflammatory cytokine production by human alveolar macrophages.

Hiroaki Yanagawa, S Sone, Takashi Haku et al. · American Journal of Respiratory Cell and Molecular Biology · 1995 · 38 citations

Inflammatory Lung Disease, Lung Inflammation, Lps-induced Il-1ra Production +20